By Kate Anderson
Daily Caller News Foundation
The Government of the United Kingdom announced Wednesday that it was placing an “emergency ban” on the private prescription and supply of puberty blockers for minors, according to a press release.
Both England and Scotland announced in March and April, respectively, that they were halting puberty blocker treatments for new patients under the age of 18 due to concerns about side effects and the largely unknown long-term impacts. The Government announced that from June 3 to September 3 private prescribers in England, Wales, and Scotland, as well as “prescribers registered in the European Economic Area (EEA) or Switzerland,” will not be able to offer puberty blockers as a treatment for minors with gender dysphoria, according to the new regulations.
“During this period no new patients under 18 will be prescribed these medicines for the purposes of puberty suppression in those experiencing gender dysphoria/incongruence under the care of these prescribers,” the announcement reads. “In addition, the government has also introduced indefinite restrictions to the prescribing of these medicines within [National Health Service] primary care in England, in line with NHS guidelines.”
The ban also bars providers from engaging in the “sale or supply” of puberty blockers for the purpose of treating minors with gender dysphoria, according to the regulations.
The ban applies to “gonadotropin-releasing hormone analogues – medicines that consist of, or contain, buserelin, gonadorelin, goserelin, leuprorelin acetate, nafarelin, or triptorelin,” according to the announcement. The drugs will still be available for patients over the age of 18 or for NHS prescriptions.
Patients under the age of 18 who have been on puberty-blocking medication for at least six months prior to June 3 will be able to continue getting a prescription, according to the regulations.
The announcement stated that the decision was “taken to address risks to patient safety” and noted that the NHS in England had made similar moves following the release of the Cass Review. The four-year review conducted by Dr. Hillary Cass, a consultant in pediatric disability and formerly the president of the Royal College of Pediatrics and Child Health, revealed that there was “weak evidence” to support puberty blockers for minors and that there was “insufficient/inconsistent” research on how the treatment impact fertility and mental health.
This story originally was published by the Daily Caller News Foundation.
Content created by The Daily Caller News Foundation is available without charge to any eligible news publisher that can provide a large audience. For licensing opportunities of our original content, please contact [email protected].
SUPPORT TRUTHFUL JOURNALISM. MAKE A DONATION TO THE NONPROFIT WND NEWS CENTER. THANK YOU!
The post Major nation orders emergency ban on puberty blockers for minors appeared first on WND.
Click this link for the original source of this article.
Author: Around the Web
This content is courtesy of, and owned and copyrighted by, https://www.wnd.com and its author. This content is made available by use of the public RSS feed offered by the host site and is used for educational purposes only. If you are the author or represent the host site and would like this content removed now and in the future, please contact USSANews.com using the email address in the Contact page found in the website menu.